Risk factors among IDUs who give injections to or receive injections from other drug users

被引:93
作者
Kral, AH [1 ]
Bluthenthal, RN [1 ]
Erringer, EA [1 ]
Lorvick, J [1 ]
Edlin, BR [1 ]
机构
[1] Univ Calif San Francisco, Sch Med, Inst Hlth Policy Studies, Urban Hlth Study, San Francisco, CA 94110 USA
关键词
D O I
10.1046/j.1360-0443.1999.9456755.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aims. To assess risk factors associated with injection drug users (IDUs) who give injections to or receive injections from other IDUs. Design and setting. IDUs were recruited into a cross-sectional study using targeted sampling methods in Oakland, Richmond, and San Francisco, California from August 1996 to January 1997 "Street docs" are IDUs who reported having given injections to other IDUs in the past month. "Injection recipients" are IDUs who reported having received injections from other people in the past month. Participants. Of 1166 IDUs interviewed, 283 (24%) reponed being injection recipients and 427 (37%) reported being street does. Measurements. Socio-demographic characteristics and injection-related risk behaviors. Findings. Injection recipients and street does were significantly more likely (p < 0.001) than other IDUs to report sharing syringes (33% of injection recipients, 21% of street does and 7% of others), cookers (71% of injection recipients, 55% of street does and 24% of others), rinse water (44% of injection recipients, 35% of street does and 13% of others), and filters (60% of injection recipients, 47% of street does and 20% of others). In a logistic regression model, injection recipients (adjusted odds ratio (AOR) = 4.29) and street does (AOR = 1.91) were more likely than other IDUs to report having shared syringes. Conclusions. Giving and receiving injections is common among IDUs in the San Francisco Bay area. Qualitative and epidemiological studies are needed to understand better the infectious disease risks associated with giving and receiving injections. interventions need to address these issues and provide practical solutions.
引用
收藏
页码:675 / 683
页数:9
相关论文
共 57 条
[1]   Epidemiology of hepatitis C [J].
Alter, MJ .
HEPATOLOGY, 1997, 26 (03) :S62-S65
[2]  
ALTER MJ, 1993, INFECT AGENT DIS, V2, P155
[3]   THE CHANGING EPIDEMIOLOGY OF HEPATITIS-B IN THE UNITED-STATES - NEED FOR ALTERNATIVE VACCINATION STRATEGIES [J].
ALTER, MJ ;
HADLER, SC ;
MARGOLIS, HS ;
ALEXANDER, WJ ;
HU, PY ;
JUDSON, FN ;
MARES, A ;
MILLER, JK ;
MOYER, LA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (09) :1218-1222
[4]  
Assagioli R., 1991, Transpersonal development
[5]  
BATTJES RJ, 1995, J ACQ IMMUN DEF SYND, V10, P90
[6]  
BLANCK RR, 1979, AM J GASTROENTEROL, V71, P164
[7]  
Bluthenthal R N, 1995, NIDA Res Monogr, V157, P212
[8]   Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995 [J].
Bluthenthal, RN ;
Kral, AH ;
Erringer, EA ;
Edlin, BR .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1998, 18 (05) :505-511
[9]   EVIDENCE AGAINST TRANSMISSION OF HEPATITIS-C VIRUS THROUGH HEMODIALYSIS ULTRAFILTRATE AND PERITONEAL-FLUID [J].
CARAMELO, C ;
NAVAS, S ;
ALBEROLA, ML ;
BERMEJILLO, T ;
REYERO, A ;
CARRENO, V .
NEPHRON, 1994, 66 (04) :470-473
[10]  
*CDC, 1991, MMWR-MORBID MORTAL W, V40, P692